IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 38,600
0.00 (0.00%)
At close: Sep 15, 2025
IntoCell Revenue
IntoCell had revenue of 39.40M KRW in the quarter ending June 30, 2025, a decrease of -97.72%. This brings the company's revenue in the last twelve months to 1.25B, down -43.08% year-over-year. In the year 2024, IntoCell had annual revenue of 2.91B with 79.72% growth.
Revenue (ttm)
1.25B
Revenue Growth
-43.08%
P/S Ratio
459.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
572.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.91B | 1.29B | 79.72% |
| Dec 31, 2023 | 1.62B | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 140.03M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |